Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC2 | Q13490 | 1/20 | 0.37 |
| ▸ | MB | P02144 | 1/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.31 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL674111 | 0.71 | CYP11B1 (0.38) | BIRC2MBCYP11B1CYP11B2PDE3B | |
| SCHEMBL7414875 | 0.69 | CYP11B1 (0.46) | MBCYP11B1CYP11B2PDE3BPDE3A | |
| SCHEMBL7420481 | 0.69 | MB (0.45) | MBPARP16PARP3 | |
| SCHEMBL673377 | 0.66 | CYP11B1 (0.42) | BIRC2MBCYP11B1CYP11B2PDE3B | |
| SCHEMBL21146603 | 0.63 | PDE3B (0.38) | BIRC2MBCYP11B1CYP11B2PDE3B | |
| SCHEMBL336931 | 0.62 | MB (0.44) | BIRC2MB | |
| SCHEMBL23272058 | 0.62 | BIRC2 (0.40) | BIRC2MBCYP11B1CYP11B2PDE3B | |
| SCHEMBL22686202 | 0.61 | BIRC2 (0.39) | BIRC2MBCYP11B1CYP11B2PDE3B | |
| SCHEMBL2183634 | 0.61 | POLB (0.51) | — | |
| SCHEMBL11078154 | 0.59 | MB (0.35) | MB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5002944-A | Compounds having cardiotonic activity | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-03-26 | — | — | US | disclosed |
| EP-0333727-A1 | HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY | RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) | 1989-09-27 | — | — | EP | disclosed |
| US-4859672-A | Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone | RORER PHARMACEUTICAL CORPORATION (US) | 1989-08-22 | — | — | US | disclosed |
| WO-1988003025-A1 | HETEROCYCLIC SUBSTITUTED BICYCLOUREAS HAVING CARDIOTONIC ACTIVITY | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1988-05-05 | — | — | WO | disclosed |